Diabetic Coma And Stroke: Understanding The Link

Diabetic comas are a life-threatening complication of diabetes that can result from very high or very low blood sugar levels. While a person in a diabetic coma is alive, they are unresponsive and cannot be awakened. Diabetic comas can be caused by hypoglycemia, hyperglycemia, or diabetic ketoacidosis. If left untreated, a diabetic coma can lead to permanent brain damage or death. This article will explore the causes, symptoms, and treatment options for diabetic comas, as well as the potential link between diabetic comas and strokes.

Diabetic ketoacidosis (DKA)

DKA typically affects people with type 1 diabetes but can also occur in those with type 2 diabetes, albeit less commonly and with less severity. It usually develops after an illness, problem with insulin therapy, or other factors such as physical or emotional trauma, heart attack, stroke, alcohol or drug misuse, and certain medications. The condition can develop slowly, with early symptoms including frequent urination, but more severe symptoms can appear quickly if left untreated. These include rapid and deep breathing, fruity-smelling breath, muscle stiffness or aches, nausea, and vomiting.

The treatment for DKA involves addressing the underlying causes, such as an infection, and stabilizing the patient through fluid replacement, electrolyte replenishment, and insulin administration. However, treatment complications can include low blood sugar, low potassium, and swelling in the brain (cerebral edema).

DKA is a medical emergency that requires immediate attention. It is important for individuals with diabetes to monitor their blood sugar and ketone levels regularly, especially when sick or stressed, to prevent and manage DKA effectively.

Cerebrovascular incidents (CVIs) are a known risk factor for the development of DKA, and DKA itself is a risk factor for stroke, particularly in children and adolescents. The stress hormone actions during CVIs may precipitate DKA, and the reverse is also true. There is a substantial risk of acute ischemic or hemorrhagic stroke during a DKA episode. Therefore, it is crucial to routinely measure serum pH, bicarbonate, blood gases, and anion gap levels in all type 1 and type 2 diabetics for the early detection of ketoacidosis.

Hyperglycemic hyperosmolar syndrome (HHS)

Hyperosmolar hyperglycemic syndrome (HHS) is a clinical condition that arises from a complication of diabetes mellitus, most commonly type 2 diabetes. It was first described by Won Frerichs and Dreschfeld in 1880. HHS is a serious and potentially fatal complication, with a mortality rate of up to 20%, which is about 10 times higher than that of diabetic ketoacidosis.

HHS is characterised by extremely high blood sugar levels, extreme dehydration, and decreased alertness or consciousness. It is often seen in people with type 2 diabetes who do not have their condition under control, as well as those who have not been diagnosed with diabetes. Various factors can trigger HHS, including infections, certain medications, non-adherence to therapy, substance abuse, and coexisting diseases.

The treatment of HHS requires a multidisciplinary approach, with consultations from an endocrinologist and an intensive care specialist. The initial focus is on correcting water loss, improving blood pressure, and increasing urine output and circulation. This is achieved through aggressive hydration with isotonic fluids and electrolyte replacement. Insulin therapy is also crucial, but it must be introduced carefully to avoid a rapid drop in blood sugar levels, which can lead to cerebral edema.

The prognosis and clinical outcome of HHS depend on several factors, including age, the degree of dehydration, and the presence of other health conditions. Overall, HHS is a life-threatening condition that requires prompt recognition and management to prevent severe complications and potential fatality.

Hypoglycaemic diabetic coma

When an individual has low blood sugar, it means their body and brain are not getting enough glucose, which is the main source of energy. This can lead to physical and mental changes and, if left untreated, can result in a coma.

The symptoms of hypoglycaemia include:

• Racing pulse or heart palpitations
• Confusion
• Altered behaviour
• Drowsiness
• Clumsiness or difficulty with coordination
• Blurred or double vision

If you suspect someone is experiencing hypoglycaemia, it is important to act quickly. Do not give them anything to eat or drink as they may choke. Call emergency services immediately and follow any instructions given by the operator. If you are trained in diabetes care, you can test the person's blood sugar and, if it is lower than 70 milligrams per decilitre (mg/dL), administer an injection of glucagon.

To prevent hypoglycaemic diabetic coma, it is crucial for individuals with diabetes to follow their diabetes treatment plan and monitor their blood sugar levels regularly.

Hyperosmolar diabetic coma

People with type 2 diabetes may develop HHS due to a combination of factors such as obesity, high body mass index (BMI), and insulin resistance. The condition is often triggered by infections, non-adherence to diabetes treatment, or certain medications that impair glucose tolerance or increase fluid loss. The risk of developing HHS is also higher in older adults, with most cases occurring in individuals in their fifth and sixth decades of life.

The symptoms of HHS include increased urination and water intake due to severe dehydration, weakness, malaise, and lethargy. In more severe cases, neurological signs such as focal neurological deficits and disturbances in visual acuity may be present. HHS can also affect the skin, causing dry skin and oral mucosa with a delayed capillary refill.

The treatment for HHS requires a multidisciplinary approach, often involving consultations with an endocrinologist and an intensive care specialist. The primary goal is to correct dehydration and insulin deficiency, which includes aggressive hydration with isotonic fluids and electrolyte replacement. Insulin therapy is also crucial, but it should be introduced gradually to avoid a rapid drop in blood glucose levels, which can lead to cerebral edema. Potassium replacement is another important aspect of treatment, as hypokalemia is a common complication.

The overall mortality rate associated with HHS can be as high as 20%, which is significantly higher than that of diabetic ketoacidosis. However, with prompt diagnosis and appropriate management, many patients can recover from this life-threatening condition.

Ketoacidotic diabetic coma

Diabetic ketoacidosis (DKA) is a dangerous and complex metabolic disorder that can lead to a diabetic coma. It is a life-threatening complication of diabetes, primarily affecting those with type 1 diabetes but also seen in some patients with type 2 diabetes. DKA occurs when the body's cells are deprived of energy, leading to the breakdown of fat for energy. This process produces toxic acids called ketones, which accumulate in the blood and turn it acidic. The defining features of DKA are hyperglycemia, ketoacidosis, and ketonuria.

The early symptoms of DKA include increased thirst and frequent urination. As the condition progresses, individuals may experience malaise, weakness, nausea, vomiting, abdominal pain, decreased appetite, and weight loss. Mental status changes, such as mild disorientation and confusion, can also occur, with frank coma being uncommon but possible, especially with severe dehydration and acidosis.

DKA is characterised by a blood sugar level greater than 250 mg/dL, a blood pH less than 7.3, and a serum concentration of ketones greater than 5 mEq/L. Laboratory studies for DKA include blood glucose tests, serum electrolyte measurements, and arterial blood gas analyses. Treatment focuses on correcting fluid loss, hyperglycemia, electrolyte disturbances, and acid-base imbalances, as well as managing any concurrent infections.

DKA is a medical emergency that requires immediate attention. It is important to monitor blood sugar levels closely and seek medical care if any symptoms of high or low blood sugar arise.

Frequently asked questions